Historical Background
Neurotensin was originally isolated from bovine hypothalamus by Carraway and Leeman in 1973 and was identified as a 13 amino acid peptide (Carraway and Leeman 1973). It was named “neurotensin” in view of its hypotensive activity. Neurotensin is produced by neurons in the central nervous system (CNS) and N cells of the gastrointestinal tract. Neurotensin acts as a hormone and a neurotransmitter or neuromodulator in the periphery and in the CNS, respectively. Neurotensin is involved in the regulation of a number of physiological functions such as analgesia, neurodevelopment, neurodegeneration, thermal regulation, metabolic regulation, pituitary hormone secretion, gastrointestinal motility, and inflammation. It was later discovered that neurotensin is also present in several types of tumors and is implicated in tumorigenesis and tumor progression. Thus, signaling pathways downstream of neurotensin could be a potential drug target for the treatment...
This is a preview of subscription content, log in via an institution.
References
Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA. 2005;102(38):13461–6.
Antonelli T, Fuxe K, Tomasini MC, Mazzoni E, Agnati LF, Tanganelli S, et al. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment. Prog Neurobiol. 2007;83(2):92–109.
Bakirtzi K, Hatziapostolou M, Karagiannides I, Polytarchou C, Jaeger S, Iliopoulos D, et al. Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors. Gastroenterology. 2011;141(5):1749–61.
Carraway R, Leeman SE. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973;248(19):6854–61.
Dobner PR. Multitasking with neurotensin in the central nervous system. Cell Mol Life Sci. 2005;62(17):1946–63.
Ferraro L, Tomasini MC, Beggiato S, Guerrini R, Salvadori S, Fuxe K, et al. Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders. Mini Rev Med Chem. 2009;9(12):1429–38.
Hwang JI, Kim DK, Kwon HB, Vaudry H, Seong JY. Phylogenetic history, pharmacological features, and signal transduction of neurotensin receptors in vertebrates. Ann N Y Acad Sci. 2009;1163:169–78.
Lafrance M, Roussy G, Belleville K, Maeno H, Beaudet N, Wada K, et al. Involvement of NTS2 receptors in stress-induced analgesia. Neuroscience. 2010;166(2):639–52.
Martin S, Dicou E, Vincent JP, Mazella J. Neurotensin and the neurotensin receptor-3 in microglial cells. J Neurosci Res. 2005;81(3):322–6.
Mustain WC, Rychahou PG, Evers BM. The role of neurotensin in physiologic and pathologic processes. Curr Opin Endocrinol Diabetes Obes. 2011;18(1):75–82.
Opland D, Sutton A, Woodworth H, Brown J, Bugescu R, Garcia A, et al. Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity. Mol Metab. 2013;2(4):423–34.
Patel AB, Tsilioni I, Leeman SE, Theoharides TC. Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism. Proc Natl Acad Sci USA. 2016;113:E7049–58. Published online September 23.
Rabinowich L, Fishman S, Hubel E, Thurm T, Park WJ, Pewzner-Jung Y, et al. Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity. J Hepatol. 2015;62(1):175–81.
Roussy G, Dansereau MA, Baudisson S, Ezzoubaa F, Belleville K, Beaudet N, et al. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity. Mol Pain. 2009;5:38.
St-Gelais F, Jomphe C, Trudeau LE. The role of neurotensin in central nervous system pathophysiology: what is the evidence? J Psychiatry Neurosci. 2006;31(4):229–45.
Stolakis V, Kalafatakis K, Botis J, Zarros A, Liapi C. The regulatory role of neurotensin on the hypothalamic-anterior pituitary axons: emphasis on the control of thyroid-related functions. Neuropeptides. 2010;44(1):1–7.
Tsuchiya Y, Hatakeyama H, Emoto N, Wagatsuma F, Matsushita S, Kanzaki M. Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes. J Biol Chem. 2010;285(45):34371–81.
Vincent JP, Mazella J, Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci. 1999;20(7):302–9.
Ye Y, Long X, Zhang L, Chen J, Liu P, Li H, et al. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma. Oncotarget. 2016;7(43):70303–22.
Zhao D, Pothoulakis C. Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides. 2006;27(10):2434–44.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
Mizuno, T. (2017). Neurotensin Receptor (NTSR). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6438-9_196-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6438-9_196-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6438-9
Online ISBN: 978-1-4614-6438-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences